Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Regenxbio (RGNX) Invested Capital (2016 - 2025)

Historic Invested Capital for Regenxbio (RGNX) over the last 12 years, with Q3 2025 value amounting to $161.5 million.

  • Regenxbio's Invested Capital fell 4643.55% to $161.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $161.5 million, marking a year-over-year decrease of 4643.55%. This contributed to the annual value of $259.7 million for FY2024, which is 1670.97% down from last year.
  • Regenxbio's Invested Capital amounted to $161.5 million in Q3 2025, which was down 4643.55% from $213.7 million recorded in Q2 2025.
  • In the past 5 years, Regenxbio's Invested Capital registered a high of $764.3 million during Q4 2021, and its lowest value of $161.5 million during Q3 2025.
  • Its 5-year average for Invested Capital is $430.7 million, with a median of $405.9 million in 2023.
  • Its Invested Capital has fluctuated over the past 5 years, first soared by 10232.74% in 2021, then plummeted by 4643.55% in 2025.
  • Quarter analysis of 5 years shows Regenxbio's Invested Capital stood at $764.3 million in 2021, then plummeted by 32.46% to $516.2 million in 2022, then plummeted by 39.61% to $311.7 million in 2023, then fell by 16.71% to $259.7 million in 2024, then plummeted by 37.82% to $161.5 million in 2025.
  • Its last three reported values are $161.5 million in Q3 2025, $213.7 million for Q2 2025, and $274.2 million during Q1 2025.